Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene

Toxicologic Pathology

Volumn 36, Issue 5, 2008, Pages 720-726

  Hong, Hue Hua L ^a   Ton, Thai Vu T ^a   Kim, Yongbaek ^b   Wakamatsu, Nobuko ^c   Clayton, Natasha P ^a   Chan, Po Chuen ^a   Sills, Robert C ^a   Lahousse, Stephanie A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Cumene; K ras; Lung; Mouse; p53

Indexed keywords

CUMENE; K RAS PROTEIN; PARAFFIN; PROTEIN P16; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 4; CHROMOSOME 6; CODON; CONTROLLED STUDY; DNA DAMAGE; DNA ISOLATION; EXON; FEMALE; GENE MUTATION; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG TUMOR; MALE; MOUSE; MUTATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR GENE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANIMALS; BENZENE DERIVATIVES; CARCINOMA; CODON; EXONS; GENES, P53; GENES, RAS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS; POINT MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS;

EID: 49749120030     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623308320280     Document Type: Article

References (46)

1. Abemethy, DJ, EV Kleymenova, J Rose, L Recio, and B Faiola (2004). Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone. Toxicol Sci, 79, 82-89.
2. Chad, AE, and C Geoff (2000). The importance of being K-ras. Cell Signal, 12, 425-34.
3. Devereux, TR, W Holliday, C Anna, N Ress, J Roycroft, and RC Sills (2002). Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis, 23, 1737-43.
4. de Vos, S, CW Miller, S Takeuchi, AF Gombart, SK Cho, and HP Koeffler (1995). Alterations of CDKN2 (p16) in non-small cell lung cancer. Genes Chromosomes Cancer, 14, 164-70.
5. Greenblatt, MS, WP Bonnett, M Hollstein, and CC Harris (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855-78.
6. Gut, I, V Nedelcheva, P Soucek, P Stopka, and B Tichavska (1996). Cytochromes p450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect, 104 (Suppl 6). 1211-18.
7. Harris, CC (1993). P53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-81.
8. Harris, CC (1996). P53 tumor suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcinogenesis, 17, 1187-98.
9. Hazardous Substance Data Bank (HSDB) (2000). Cumene (CASRN: 98-82-8): Annual Production in U.S. Chemical and Engineering News, Vol. 72. Bethesda, MD. USA: Toxicology & Environmental Health Information Program, National Library of Medicine, 13. (4/11/94). ( http://toxnet.nlm.nih.gov ).
10. Hazardous Substance Data Bank (HSDB) (2003). Cumene. In Toxicology Information Program. Bethesda, MD, USA: National Library of Medicine.
11. Hegi, ME, P Soderkvist, JF Foley, R Schoonhoven, JA Swenberg, F Kari, R Maronpot, MW Anderson, and RW Wiseman (1993). Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis, 14, 803-10.
12. Hong, HL, TR Devereux, RL Melnick, GA Boorman, and RC Sills (2000). Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol Pathol, 28, 529-34.
13. Hong, HL, TV Ton, TR Devereux, C Moomaw, N Clayton, P Chan, JK Dunnick, and RC Sills (2003). Chemical-specific alterations in ras, p53, and β-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol, 191, 227-34.
14. Hong, HL, J Dunnick, R Herbert, TR Devereux, Y Kim, and RC Sills (2007). Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT. Environ Mol Mutagen, 48, 299-306.
15. Hsu, SM, L Raine, and H Fanger (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem, 29, 577-80.
16. Jackson, L (1985). Test Rule Support Document Cumene (p. 170). Syracuse, NY: Syracuse Research Corporation. SRC-TR-85-098.
17. Janssen, YMW, B Van Houten, PJA Borm, and BT Mossman (1993). Cell and tissue responses to oxidative damage. Lab Invest, 69, 261-74.
18. Kino, K, and H Sugiyama (2005). UVR-induced G-C to C-G transversions from oxidative DNA damage. Mutation Res, 571, 33-42.
19. Kratzke, RA, TM Greatens, JB Rubins, MA Maddaus, DE Niewoehner, GA Niehans, and J Geradts (1996). Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res, 56, 3415-20.
20. Lambertini, L, K Surin, TT Ton, N Clayton, J Dunnick, Y Kim, HL Hong, TR Devereux, and RC Sills (2005). Analysis of p53 tumor suppressor gene, H-ras protooncogene and profilerating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/SKh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy). Toxicol Pathol, 33, 292-99.
21. Le Calvez, F, A Mukeria, JD Hunt, O Kelm, RJ Hung, P Taniere, P Brennan, P Boffetta, DG Zaridze, and P Hainaut (2005). TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res, 65, 5076-83.
22. Lee, EW (1987). Cumene, Section 1.5. In R Snyder (Ed.), Ethel Browning's Toxicity and Metabolism of Industrial Solvents, Hydrocarbons, Vol. I, 2. New York, NY: Elsevier Science Publishers.
23. Maronpot, R, MW Anderson, and RW Wiseman (1993). Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis, 14, 803-10.
24. Maronpot, RR, T Fox, D Malarkey, and T Goldsworthy (1995). Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology, 101, 125-56.
25. Meuwissen, R, and A Berns (2005). Mouse models for human lung cancer. Genes Dev, 19, 643-64.
26. National Toxicology Program (NTP) (1996). In Vivo Cytogenetics Testing Results for Cumene, Micronucleus Induction Results. Research Triangle Park, NC: NIEHS. (Case No. 98-82-8) NTP TR 542.
27. Nikitin, AY, A Alcaraz, MR Anver, RT Bronson, RD Cardiff, D Dixon, AE Fraire, EW Gabrielson, WT Gunning, DC Haines, MH Kaufman, RL Linnoila, RR Maronpot, AS Rabson, RL Reddick, S Rehm, N Rozengurt, HM Schuller, EN Shmidt, WD Travis, JM Ward, and T Jacks (2004). Classification of proliferative pulmonary lesions of the mouse recommendations of the mouse models of human cancers consortium. Cancer Res, 64, 2307-16.
28. Osada, H, and T Takahashi (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene, 21, 7421-34.
29. Patel, AC, CH Anna, JF Foley, PS Stockton, FL Tyson, JC Barrett, and TR Devereux (2000). Hypermethylation of the p16Ink4a promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines. Carcinogenesis, 21, 1691-1700.
30. Research Triangle Institute (RTI) (1989). Metabolism, Disposition and Pharmacokinetics of Cumene in F 344 Rats Following Oral. In IV Administration or Nose-Only Inhalation Exposure. Research Triangle Park, NC: RTI. RTI/4353-01F.
31. Reynolds, SH, SJ Stowers, RM Patterson, RR Maronpot, SA Aaronson, and MW Anderson (1987). Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science, 237, 1309-16.
32. Rodenhuis, S, ML Van De Watering, WJ Mooi, SG Evers, N Van Zandwijk, and JL Bos (1987). Mutational activation of the K-ras oncogene - a possible pathogenetic factor in adenocarcinoma of the lung. New Engl J Med, 317, 929-35.
33. Rodin, SN, and AS Rodin (2005). Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol, 15, 103-12.
34. Santillo, M, P Mondola, R Seru, T Annella, S Cassano, I Ciullo, MF Tecce, G Iacomino, S Damiano, G Cuda, R Paterno, V Martignetti, E Mele, A Feliciello, and EV Avvedimento (2001). Opposing functions of Ki- and Ha-ras genes in the regulation of redox signals. Curr Biol, 11, 614-19.
35. Sato, A, and T Nakajima (1987). Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand J Work Environ Health, 13, 81-93.
36. Shigenaga, MK, and BN Ames (1991). Assays for 8-hydroxy-2′- deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radical Biol Med, 10, 211-16.
37. Sills, RC, HL Hong, A Greenwell, RA Herbert, GA Boorman, and TR Devereux (1995). Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis, 16, 1623-28.
38. Sills, RC, HL Hong, RL Melnick, GA Boorman, and TR Devereux (1999). High frequency of codon 61 K-ras A to T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis, 20, 657-62.
39. Sills, RC, HL Hong, G Flake, C Moomaw, N Clayton, GA Boorman, J Dunnick, and TR Devereux (2004). O-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis. Carcinogenesis, 25, 605-12.
40. Snyder, R, and CC Hedli (1996). An overview of benzene metabolism. Environ Health Perspect, 104 (Suppl 6). 1165-71.
41. Tam, AS, JF Foley, TR Devereux, RR Maronpot, and TE Massey (1999). High frequency and heterogenous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Cancer Res, 59, 3634-40.
42. Tchou, J, H Kasai, S Shibutani, M-H Chung, J Laval, AP Grollamn, and S Nishimura (1991). 8-Oxogyanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci USA, 88, 4690-94.
43. US Environmental Protection Agency (EPA) (1997). Toxicological Review of Cumene, EPA's Summary Information on the Integrated Risk Information System. Washington, DC: EPA.
44. Valentine, JL, SS Lee, MJ Seaton, B Asgharian, G Farris, JC Corton, FJ Gonzalez, and MA Medinsky (1996). Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol, 141, 205-13.
45. Wakamatsu, N, BC Collins, JS Parker, M Tessama, ND Clayton, TT Ton, HL Hong, S Belinsky, TR Devereux, RC Sills, and SA Lahousse Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and modification of histone, contribute to the pathogenesis of cumene-induced lung tumors. Toxicol Pathol. (Forthcoming).
46. Zhang, Z, Y Wang, HG Vikis, L Johnson, J Liu, MW Anderson, RC Sills, HL Hong, TR Devereux, T Jacks, KL Guan, and M You (2001). Wild-type Kras 2 can inhibit lung carcinogenesis in mice. Nat Genet, 29, 25-33.